Modifying oral cytotoxics: what are the considerations?
Haywood, Alison, and Glass, Beverley (2009) Modifying oral cytotoxics: what are the considerations? Australian Pharmacist, 28 (8). pp. 674-677.
|PDF (Published Version) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader|
View at Publisher Website: http://www.psa.org.au/site.php?id=4497
It is well known that Australia's population is ageing and that the incidence of cancer is highest in older age groups, so despite the fact that cancer incidence rates in Australia for both men and women are projected to remain stable to 2011, the total number of new cases of cancer is projected to increase. To reduce the resulting burden on the health care system it is imperative that patients be treated at home. The introduction of several new oral cytotoxics, allowing the administration of chemotherapeutic agents outside of traditional clinic settings, is making this goal attainable. While studies have shown that patients receiving chemotherapy prefer the oral route of administration over the parenteral route, there are many new challenges in administering these agents in non-traditional environments. Pharmacists. because of the their accessibility, have an important role to play in counselling patients on the safe and effective use of these cytotoxics, thus playing a pivotal role in the achievement of favourable therapeutic outcomes for these patients.
|Item Type:||Article (Refereed Research - C1)|
Reproduced with permission from Australian Pharmacist.
|FoR Codes:||11 MEDICAL AND HEALTH SCIENCES > 1115 Pharmacology and Pharmaceutical Sciences > 111503 Clinical Pharmacy and Pharmacy Practice @ 100%|
|SEO Codes:||92 HEALTH > 9299 Other Health > 929999 Health not elsewhere classified @ 100%|
|Deposited On:||30 Mar 2010 11:59|
|Last Modified:||12 Feb 2011 03:25|
Last 12 Months: 23
Repository Staff Only: item control page